• FDA approves Ryaltris nasal spray for seasonal allergic rhinitis

    3 days ago - By Healio

    The FDA approved olopatadine hydrochloride and mometasone furoate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis in adults and children aged 12 years and older, according to a press release.
    Olopatadine hydrochloride and mometasone furoate is a metered, fixed-dose, aqueous suspension, prescription drug product nasal spray. It contains 665 µg olopatadine hydrochloride, a histamine-1 receptor inhibitor, and 25 µg mometasone furoate, a corticosteroid.
    “The FDA's approval of Ryaltris represents a
    Read more ...

     

  • FDA Approves Ryaltris Nasal Spray for Seasonal Allergic Rhinitis

    FDA Approves Ryaltris Nasal Spray for Seasonal Allergic Rhinitis

    3 days ago - By Medscape

    The fixed-dose nasal spray is already approved and marketed in eight countries, including the United Kingdom and Australia.
    FDA Approvals
    Read more ...